Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06HBT
|
||||
Former ID |
DNCL001812
|
||||
Drug Name |
LT-1951
|
||||
Indication | Coronary artery disease [ICD9: 410-414, 429.2; ICD10:I20-I25] | Phase 1/2 | [521773] | ||
Company |
Lumen Therapeutics
|
||||
Structure |
Download2D MOL |
||||
Formula |
C54H110N36O10
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Nitric oxide synthase, inducible | Target Info | Modulator | [526624] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
KEGG Pathway | Arginine biosynthesis | ||||
Arginine and proline metabolism | |||||
Metabolic pathways | |||||
Calcium signaling pathway | |||||
HIF-1 signaling pathway | |||||
Peroxisome | |||||
Salmonella infection | |||||
Pertussis | |||||
Leishmaniasis | |||||
Chagas disease (American trypanosomiasis) | |||||
Toxoplasmosis | |||||
Amoebiasis | |||||
Tuberculosis | |||||
Pathways in cancer | |||||
Small cell lung cancer | |||||
NetPath Pathway | IL1 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.